|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Antibacterial defenses in the airway are dependent on multifactorial influences that determine the composition of both fluid and/or electrolytes at the surface of the airway and the secretory products that aid in bacterial killing and clearance. In cystic fibrosis (CF), these mechanisms of airway protection may be defective, leading to increased colonization with Pseudomonas aeruginosa. Submucosal glands, a predominant site of cystic fibrosis transmembrane conductance regulator (CFTR) protein expression in the airway, have been hypothesized to play an important role in protection of the airway. Furthermore, recent studies have suggested that the salt concentration at the airway surface may be a key factor in regulating the activity of antibacterial substances in the airway. To explore these issues, we have used a new model of the ferret tracheal airway to evaluate the contribution of submucosal glands in regulating airway surface fluid and electrolyte composition. Using tracheal xenograft models with and without submucosal glands, we have characterized several aspects of airway physiology that may be important in defining antibacterial properties. These endpoints included the contribution of submucosal glands in defining bioelectric properties of the surface airway epithelium, airway surface fluid (ASF) chloride composition, ASF volumes, and secretion of the antibacterial factor lysozyme. Findings from these studies demonstrate a significantly elevated secreted fluid volume (Vs) and chloride concentration ([Cl]s) in ASF from airways with submucosal glands (Vs = 47 ± 4 µl; [Cl]s = 128 ± 5 mM), as compared with xenograft airways without glands (Vs = 36 ± 2 µl; [Cl]s = 103 ± 6 mM). Furthermore, a temperature labile factor secreted by submucosal glands appears to alter the baseline activation of 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and/or diphenylamine-2-carboxylic acid-sensitive chloride channels in the surface airway epithelium. Lastly, the lysozyme content of tracheal airways with submucosal glands was 8.5-fold higher than were airways without glands. These studies demonstrate that submucosal glands affect both the ionic composition and bioelectric properties of the airway and suggest that models evaluating antibacterial properties of the airway in CF should take into account the contribution of glands in airway physiology.
| |
Introduction |
|---|
|
|
|---|
Cystic fibrosis (CF) is characterized by abnormal regulation of chloride transport due to defects in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) (1). Chronic lung infections, bronchiectasis, and respiratory failure are the primary causes of mortality in CF (2). Numerous pathophysiologic mechanisms have been proposed to be involved in the progression of chronic bacterial infection in the CF lung, including improper fluid balance at the airway surface (3) and altered ionic composition of the airway fluid, which might create a milieu conducive to infection (6). Pathology in the CF lung is characterized by chronic bacterial infection in the peripheral small airways (2, 9). Hence, the small airways have been traditionally thought to be the site at which defective CFTR leads to the CF lung phenotype. However, the localization of high levels of CFTR messenger RNA (mRNA) and protein to other regions in the lung, such as submucosal glands in the conducting airways, suggests that these regions may also be involved in the pathoprogression of airway infection (10, 11). Several lines of evidence suggest that submucosal glands may be important in this disease, including the following: (1) submucosal glands appear to have defined early pathophysiology in the CF neonatal lung (12- 14); (2) in the cartilaginous airways, CFTR expression is found at the highest levels in submucosal gland serous tubules (10, 11); and (3) these serous cells secrete high levels of antibacterial proteins such as lysozyme and lactoferrin (15, 16).
Two central hypotheses underlie mechanisms relating improper fluid and electrolyte balance to increased bacterial colonization in the CF airway. The most traditional view has been that increased Na absorption and decreased chloride secretion in CF leads to dehydration of the airway surface fluid (ASF) layer, which in turn leads to thick mucus with altered physical properties and impaired mucociliary clearance of inhaled bacteria (5, 17). This mechanism suggests that the innate antibacterial properties of surface airways are unaltered in CF, but the mechanical properties of clearance are impaired. In contrast, recent studies comparing the innate defense mechanisms of ASF from CF and non-CF epithelia have suggested that a higher concentration of NaCl in CF may affect the antibacterial properties of ASF (6, 17). However, this issue still remains a point of contention as others have seen little difference in the ionic composition of ASF from CF and non-CF patients (18). Such studies have led to a resurgence of investigation comparing the bactericidal and clearance properties of CF and non-CF airway epithelium in an effort to better understand the mechanisms underlying regulation of NaCl concentration in ASF and to characterize antibacterial substances in the airway that may have altered activity in CF (17, 19).
Several model systems have been used to functionally evaluate submucosal gland secretions and bioelectric properties. These models have included the technically challenging cannulation of single gland ducts for fluid composition analysis (23) as well as a comparison of distal porcine airways with and without submucosal glands (24). Both of these models support the importance of submucosal glands in chloride and bicarbonate secretion in the airway. Other investigators have demonstrated that the bioelectric properties change with the diameter of the airway (24). Although these studies provide indirect evidence for the importance of submucosal glands, which also decrease with the diameter of the airway, they are incapable of separating changes in surface airway biology and composition of channels with parallel changes in the abundance of submucosal glands. To this end, we have developed ferret xenograft models of the tracheal airway in which surface airway epithelial cells have the defined anatomic characteristics of tracheal epithelium and only the abundance of submucosal glands is altered. These airway models with and without submucosal glands can be directly used to infer the contribution of submucosal glands in regulating ASF fluid and electrolyte composition in the absence of regional differences of the surface airway epithelium.
| |
Materials and Methods |
|---|
|
|
|---|
Generation of Ferret Tracheal Xenografts with and without Submucosal Glands
Ferret proximal airway xenografts without submucosal glands were generated from ferret adult primary tracheal epithelial cells. In these experiments, adult ferret tracheal surface airway epithelial (SAE) cells were prepared by first rinsing ferret tracheas in Eagle's minimum essential medium (MEM) with antibiotics (50 µg/ml ceftazidime, 50 µg/ml colymycin, 2.5 µg/ml fungizone, 40 µg/ml tobramycin, 100 U/ml penicillin, and 100 µg/ml streptomycin) for 4 h at 4°C with four to five changes. Tracheas were then filled with 0.1% protease-14 in MEM, the ends ligated closed, and incubated for 36 h at 4°C. Cells were then harvested, washed twice with 10% fetal bovine serum/MEM, and directly seeded at a density of 1 × 106 cells into donor Fisher rat tracheas denuded of all viable epithelia by freeze thawing three times and rinsing in MEM (27, 28). Ferret xenografts were then ligated to flexible plastic tubing and transplanted subcutaneously into athymic mice as previously described (27, 28). The xenograft airway lumens remained air filled during development and were flushed every 3 d to remove accumulated mucus. These reconstituted tracheas developed a fully differentiated epithelium without submucosal glands by 4 wk after transplantation. In contrast to these reconstituted xenografts, native 5-wk-old ferret tracheas were used to model proximal airways with intact submucosal glands. Native ferret airways were generated from tracheas with a similar lumenal diameter to rat tracheal xenografts with reconstituted adult SAE cells described previously. Native ferret xenografted tracheas were generated by ligating 5-wk ferret tracheas to flexible plastic tubing followed by transplantation in athymic mice.
Morphologic Analysis of Xenografts
Xenograft airways were morphologically evaluated using several criteria. First, for light level analysis, frozen sections of xenografts fixed in 4% paraformaldehyde were used to evaluate the overall level of epithelial reconstitution and presence of submucosal glands. Second, transmission electron microscopy was used to evaluate the cellular architecture of the surface airway epithelium and submucosal glands. In these studies, xenografts were infused in situ with fixative (2% glutaraldehyde, 2% paraformaldehyde, 0.07 M sodium phosphate, pH 7.2), excised, and fixed in the same solution overnight at 4°C. Xenografts were then decalcified by incubation in Cal-Rite decalcification solution (Richard Anderson Inc.) for 2 h at room temperature and then divided into three equally sized rings for transmission electron microscopy processing as previously described (29). Morphometry evaluating the percentage of ciliated, nonciliated columnar, goblet, intermediate, and basal cells in the surface airway epithelium was performed on three equally spaced quadrants obtained over the 1-cm length of each tracheal graft. In total, two independent xenografts were evaluated for each type (with or without glands) from a total of six electron microscopy (EM) samples. The following criteria were used to identify and quantitate cell types: (1) ciliated cells, as containing cilia at the apical membrane; (2) nonciliated columnar cells, as columnar cell types reaching the apical membrane with no visible cilia or mucous granules; (3) goblet cells, as columnar cell types with visible secretory granules; (4) intermediate cells, as noncolumnar triangular-shaped cells in contact with the basal lamina and rising at least one-third the height of the epithelium but not reaching the apical membrane; and (5) basal cells, as low lying electron-dense, cuboidal-shaped cells in contact with the basal lamina and containing a high nuclear-to-cytoplasmic ratio. At least 1,100 cells were quantified from six total samples from each xenograft type.
In Vivo Transepithelial Potential Difference Measurements in Ferret Tracheal Xenografts
In vivo transepithelial potential differences (PDs) were measured in xenografts as previously described (28, 30). These methodologies have been successfully used in the human bronchial xenograft model comparing CF with non-CF airway epithelium (28, 30). Briefly, xenografts were continuously perfused with buffers through a syringe pump at 150 µl/min. The sequence of buffers perfused typically included: (1) Hepes phosphate-buffered Ringer's solution (HPBR) containing 10 mM Hepes, pH 7.4, 145 mM
NaCl, 5 mM KCl, 1.2 mM MgSO4, 1.2 mM Ca-gluconate, 2.4 mM
K2HPO4, 0.4 mM KH2PO4, (2) HPBR with 100 µM amiloride, (3)
HPBR chloride-free (using gluconate in place of chloride), 100 µM
amiloride, (4) HPBR chloride-free, 100 µM amiloride, 200 µM
8-cpt-cyclic adenosine monophosphate (cAMP), 10 µM forskolin, (5) HPBR chloride-free, 100 µM amiloride, 200 µM 8-chlorophenylthio (cpt)-cAMP, 10 µM forskolin, 100 µM uridine tri-phosphate (UTP), and (6) HPBR. Selected experiments were also
performed using chloride channel blockers 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) and diphenylamine-2-carboxylic acid (DPC) at 1-mM concentrations (31) and bumetanide (a
basolateral Na+-K+-2Cl
cotransport blocker) at 100-µM concentrations (32). Millivolt recordings were captured through a
voltmeter and data-linked directly to a computer, which recorded
millivolt measurements at 5-s intervals.
Reconstitution experiments were used to evaluate the effects of
glandular secretions on the bioelectric properties of the surface
airway epithelium. In these studies, secretions collected from xenograft airways with submucosal glands were subsequently used to
pretreat xenografts airways without glands before functional measurements. The goal of these studies was to determine whether the decreased baseline unstimulated chloride permeability seen in xenograft airways with submucosal glands was due to inhibitory factor(s) in glandular secretions. To this end, transepithelial PDs were measured in xenograft airways without submucosal
glands under the following conditions: (1) untreated for baseline
measurements, (2) pretreated with 100 µl of secretions from xenograft airways with submucosal glands for 1 h before PD measurements, or (3) pretreated with 100 µl of boiled (10 min) secretions from xenograft airways with submucosal glands for 1 h
before PD measurements. Glandular secretions used for these reconstitution experiments were collected from xenografts by perfusion with 100 µl HPBR. The fluid was cleared from particulate
mucin by centrifugation and stored at
80°C before use. Each
xenograft airway was assayed three times (once for each condition) with a rest interval of 2 to 3 d between PD measurements.
Chloride Content of ASF in Xenograft Airways
The content of chloride in the ASF was calculated using radioisotopic tracers as previously described (21). Fully differentiated 5-wk
ferret tracheal xenografts (air filled) were flushed with 1 ml of
F12 medium followed by air at 48 h before functional measurements. After 48 h of equilibration, the lumenal contents were collected by flushing the xenograft airway with 100 µl of a 5% (iso-osmotic) mannitol solution containing 20,000 total cpm of H3-
inulin. The dilution of H3-inulin counts in the effluent was used to
calculate the volume of ASF secretions (Vs). Calculations to account for fluid loss in the trachea during sample collection (Vl)
were also taken into consideration by quantitating the amount of
radioactivity in a second large wash (1 ml) of the xenograft lumen
after sample collection, as previously described (21). Formulas
for calculating the ASF volume (Vs) were based on the following
equation: Vs = Ve
Vi + Vl, where the input volume (Vi) was
equal to 100 µl and the effluent volume (Ve) was equal to {([inulin]i/[inulin]e) × (Vi-Vl)} (21).
The chloride content of ASF ([Cl]s) was directly measured on
duplicate 10-µl samples using a solid-state, chloride-specific electrode and calculated against chloride standards in 5% mannitol. The linear range of these calculations was from 1 to 200 mM
NaCl. Formulas for calculating the ASF chloride concentrations
were based on the following equation: [Cl]s = {[Cl]e × (Vs + Vi
Vl)}/Vs, where the concentration of chloride in the effluent ([Cl]e)
was empirically measured (21).
Western Blot Analysis of Lysozyme Content in ASF
The lysozyme content of xenograft ASF secretions collected as described previously was evaluated by Western blot analysis using antilysozyme antibodies (Chemicon International Inc., Temecula, CA). In brief, 10 µl (approximately one-fourth of secretory volume) of ASF was denatured by boiling in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer, electrophoresed on a 10% SDS-PAGE, transferred to a nitrocellulose membrane, and probed with antilysozyme antibody. Immunoreactivity was detected with a peroxidase-conjugated secondary antibody and chemiluminescence detection on X-ray film. The content of lysozyme in the secretions of xenografts with (n = 13) and without (n = 13) submucosal glands was compared by densitometry of Western blots.
Statistical Methods
Comparisons between experimental data from xenografts with and without submucosal glands were performed using the two-tailed Student's t test. P values of < 0.05 were considered to demonstrate significant differences between data sets.
| |
Results |
|---|
|
|
|---|
Generation of Ferret Tracheal Xenografts with and without Submucosal Glands
By expanding progenitor cell populations with a pluripotent capacity for airway surface epithelial differentiation but limited capacity for submucosal gland development, we have developed a xenograft method for generating fully differentiated ferret proximal airways without submucosal glands (Figures 1C and 1D). In contrast, native airway xenografts generated from 5-wk-old ferret tracheas contain a fully differentiated surface airway epithelium and submucosal glands (Figures 1A and 1B). Submucosal glands of 5-wk-old ferret tracheal xenografts contain both serous and mucous tubules, markers of gland differentiation (Figures 1G and 1H). To assess whether the surface airway epithelium of reconstituted and native tracheal xenografts had similar cellular compositions, morphometry was performed on electron micrographs of each xenograft type. In these studies, the percentages of ciliated, nonciliated columnar, goblet, intermediate, and basal cells were evaluated in two independent xenografts of each type (Figures 1E and 1F). Results from these studies, which evaluated at least 1,100 cells from each type of xenograft, are presented in Table 1. No significant differences in the cellular composition of airway xenografts with and without submucosal glands were observed.
|
|
Lysozyme Production Is Significantly Greater in Xenograft Airways with Submucosal Glands
As an indicator of submucosal gland function in native ferret xenografts, we assessed the level of lysozyme expression in ASF from xenografts with submucosal glands compared with the levels in reconstituted xenografts without glands. Lysozyme is an antibacterial enzyme known to be abundantly produced by serous cells of submucosal glands. In these Western blot studies, lysozyme levels were 8.5-fold higher (P < 0.001, n = 13) in ASF from the xenografts with submucosal glands (Figure 2). At present, it is unclear whether cross-reactivity of our antibodies with mouse lysozyme may contribute to a low background level of lysozyme in both types of xenografts. However, these results demonstrate that submucosal glands contribute more lysozyme to the ASF than the surface airway epithelium does.
|
In Vivo Transepithelial PD Measurements in Ferret Tracheal Xenografts
Bioelectric properties of xenograft airways with and without
submucosal glands were evaluated using in vivo transepithelial PD measurements to gain insight into ion transport
differences between these two structurally distinct airways.
Typical tracings from airways with and without submucosal glands are demonstrated in Figures 3A and 3B, respectively. A summary of bioelectric properties for greater
than 28 xenografts of each type (Figure 3C) present several findings supporting the hypothesis that submucosal
glands affect the overall ion transport properties of the airway. These findings included: (1) a significantly higher
mV PD in response to amiloride in xenografts with submucosal glands (P < 0.002); (2) a significantly higher
mV
PD in response to a Cl-free buffer without a cAMP agonist
in airways without submucosal glands (P < 0.001); and
(3) a significantly higher cAMP/forskolin and UTP
mV PD
response in airways with submucosal glands (P < 0.001). Despite these functional differences in bioelectric properties, the total
mV PD of combined Cl-free/cAMP/forskolin/UTP induced changes in xenografts without submucosal glands (
47.9 ± 3.0 mV, n = 31) was not significantly
different (P < 0.225) from xenograft airways with submucosal glands (
42.0 ± 3.7 mV, n = 28). We were intrigued
by the finding that airways without submucosal glands had
a significantly higher baseline activated Cl permeability (i.e., in the absence of cAMP agonists) than did airways
with submucosal glands. Such a finding suggests that the
presence of submucosal glands may suppress the baseline
activation of surface airway epithelial Cl channels.
|
To test the hypothesis that glandular secretions inhibit
the baseline activation of chloride channels in the surface
airway epithelium, glandular secretions were collected from
native xenografts with glands and used to pretreat reconstituted xenografts without glands before transepithelial
PD measurements. Results shown in Figure 4 clearly demonstrate that the baseline chloride permeability of glandless xenografts is decreased by a 1-h pretreatment with glandular secretions. In contrast, boiling of glandular secretions before pretreatment abolished the functional effect on baseline chloride permeability of airways without submucosal glands (Figure 4A). As additional negative controls,
two supplementary experimental manipulations were performed, which included: (1) treatment of glandless xenografts with fluid collected from the same xenograft type
before PD measurements and (2) treatment of xenografts
with glands with fluid collected from xenografts without
glands before PD measurements. In both these cases, no
significant differences in the PD profiles of the respective
xenograft type were observed after exposure to secretions
(data not shown). These results demonstrate that the phenotypic bioelectric properties of airways without submucosal glands can be altered to appear like airways with
submucosal glands through the action of a compound secreted by glands. This finding can be best depicted by comparing the ratio of Cl-free to cAMP/forskolin
PDs, as
shown in Figure 4B. In this comparison, the PD ratios of
glandless airways were significantly altered after treatment with submucosal gland secretions (P < 0.002). In
contrast, no significant difference in this ratio was seen in
glandless airways after treatment with boiled secretions.
Furthermore, in all xenografts, the increased baseline chloride permeability in the presence of Cl-free solutions was
correlated with a decreased amiloride-sensitive change in
the PD. These bioelectric data also suggest that amiloride-sensitive surface airway epithelial Na channels may be activated by submucosal gland secretions directly or perhaps
through alterations in the activity of other associated ion
channels. Given the previously described phenomenon that
activated CFTR inhibits epithelial sodium channel (ENaC)
activity (4), these findings may implicate CFTR in the functional pathway leading to high levels of baseline, unstimulated chloride permeability in xenografts without submucosal glands. If this were the case, one might hypothesize
that submucosal gland secretions inhibit the baseline activation of CFTR in the surface airway epithelium, leading
to increased ENaC activity. To determine which potential chloride channel(s) might be activated solely by a chloride
chemical gradient in xenograft airways without submucosal glands, we evaluated the pharmacologic inhibitory
profile of the transepithelial PD under Cl-free conditions.
|
Several candidate chloride channels, including Ca+-activated Cl channels, CFTR, and/or the outward rectifying
chloride channel (ORCC), could be responsible for the
higher level of baseline chloride permeability in xenograft
airways without submucosal glands. Both the Ca+-activated Cl channel and ORCC are inhibited by the chloride
channel blocker DIDS but not by DPC (31). In contrast,
CFTR is inhibited by DPC but not by DIDS (31). Results
presented in Figure 5 demonstrate that DIDS only partially (9.4 ± 0.4%) inhibited the Cl-free
PD of reconstituted xenografts without submucosal glands. In contrast, DPC inhibited 44.0 ± 6.1% of the Cl-free response. The
additive inhibition of Cl-free induced chloride permeability by both DIDS and DPC suggests that multiple chloride
channels in the surface airway epithelium are involved in
this electrogenic pathway (i.e., Ca+-activated Cl channels,
CFTR, and/or ORCC). The baseline activity of these channels appears to be elevated in airways without submucosal glands and inhibited by glandular secretions.
|
Electrolyte Composition of ASF in Xenografts with and without Submucosal Glands
Using a sensitive method for calculating Vs and [Cl]s, we sought to directly evaluate whether the presence of submucosal glands affected the steady-state concentration of chloride in the airway. The results from these comparisons are shown in Figure 6. Of note is the fact that ASF volumes from ferret airway xenografts without submucosal glands (36 ± 2 µl) were significantly (P < 0.05) lower than those in tracheal airways with submucosal glands (47 ± 4 µl). Furthermore, ASF volumes in reconstituted ferret xenograft airways were extremely similar to human bronchial xenografts without submucosal glands (35 µl) (21). These findings suggest that the ferret airway xenografts closely mimic human airway epithelium with respect to fluid transport properties. However, most important to the present study, these findings directly demonstrate that submucosal glands influence the steady-state volume of fluid and secretions in the airway lumen of this xenograft model.
|
Ferret tracheal airways with and without submucosal glands also demonstrated significant differences (P < 0.001) in the ASF chloride content (Figure 6). Ferret xenograft airways with submucosal glands had a mean chloride concentration of 128 ± 5 mM, whereas the chloride content in airways without submucosal glands was 103 ± 6 mM. These data demonstrate that submucosal glands not only contribute to the volume but also contribute significantly to the chloride content of ASF.
| |
Discussion |
|---|
|
|
|---|
The present studies evaluating the contribution of submucosal glands in regulating the composition of ASF have used novel xenograft models, allowing direct comparisons of fully differentiated airways with and without submucosal glands. The advantages of this model system include the fact that grafted airways are vascularized and air-exposed, yet easily accessible for functional studies. In vitro studies evaluating polarized monolayers cannot take into account the contribution of glandular structures, whereas the present xenograft models can. Furthermore, morphometric analyses confirmed that the cytoarchitecture of the surface epithelium of gland-containing and glandless xenograft airways was not significantly different. Thus, these models provide a superior system for dissecting the relative contribution of submucosal glands to airway physiology.
Evaluation of the bioelectric properties of glandular versus nonglandular ferret tracheal airways demonstrated several significant differences with respect to anion permeability. Most notably, the ratio of Cl-free to cAMP-stimulated
changes in transepithelial PD is significantly different between airways with and without glands. In the absence of
submucosal glands, higher baseline active chloride permeability in the presence of low lumenal chloride suggests
glands may inhibit the activation state of surface airway epithelial chloride channels. Pretreatment of glandless airways with secretions harvested from xenografts with submucosal
glands reversed the ratio of low chloride to cAMP-inducible
transepithelial PD, providing support for this hypothesis.
These effects were not the result of changes in the overall
capacity of airways to transport chloride, as the total
PD in
the presence of low chloride, cAMP, and UTP remained
relatively constant before and after conditioning of grafts
with secretions (
58.7 ± 5.0 mV for grafts treated with secretions and
56.2 ± 3.8 mV for untreated grafts). Such a
hypothesis, that glandular secretions alter the bioelectric
properties of the surface airway epithelium, is not unreasonable, given the fact that glands have been shown to secrete
adenosine triphosphate, phosphatases, ecto-adenosine triphosphatases, and other molecules that may inhibit or activate
surface airway epithelial receptors controlling chloride
channels (33, 34). Alternatively, submucosal glands might
invoke the secretion of some factor from the surface airway
epithelium in xenografts with submucosal glands, which is
responsible for inhibiting the baseline activation of chloride channels in xenografts without glands. Experiments demonstrating that boiled glandular secretions lose their capacity
to alter the baseline chloride permeability of airway epithelium without glands suggest that the effector molecule is
heat labile and hence might be an enzyme. Multiple types of
channels appear to be responsible for the higher chloride
permeability in airways without glands because they are inhibited by both DIDS and DPC. However, the majority of
the response appears to be primarily sensitive to DPC and
could in fact be attributable to CFTR.
Differences in bioelectric properties of xenograft airways with and without submucosal glands were mirrored
by differences in ASF chloride content. ASF chloride from
glandular airways was significantly higher than that in airways without submucosal glands. Several hypotheses might
account for these differences. First, as previously demonstrated by our laboratory (21), mucin interferes to some
extent with chloride determination measurements. High concentrations of mucin in ASF from xenografts with submucosal glands could lead to an overestimation (12% at 0.5 mg/ml mucin) of the chloride concentration. Although it is
difficult to assess differences in the free mucin content of
ASF because much is precipitated in aggregates, this alone
is unlikely to account for the 24% higher level of chloride
in ASF from xenografts with submucosal glands. Second,
submucosal glands may secrete chloride-rich fluid into the
airway. Given the fact that CFTR is highly abundant in
submucosal glands, this hypothesis seems reasonable. In
contrast, others have suggested that glandular secretions
from human nasal epithelium are hypotonic. However, these
studies were performed under conditions of stimulated
glandular secretion (18), whereas the present study evaluated baseline, unstimulated conditons. Third, the higher baseline activation of chloride channels in xenograft airways without submucosal glands suggests an alternative
hypothesis that glandular secretions inhibit absorption of
NaCl in the airway by modulating chloride permeability.
One point in question regarding this alternative hypothesis pertains to the pathways for sodium absorption in the
ferret airway. Amiloride-sensitive sodium permeability is
significantly lower in ferret airways without submucosal
glands. Treatment of these glandless airways with secretions harvested from xenografts with glands was capable of
increasing amiloride-sensitive sodium permeability 4-fold,
to near the level seen in native xenograft airways with submucosal glands. Furthermore, changes in amiloride-sensitive sodium permeability produced by glandular secretions
appeared to inversely mirror changes in the level of unstimulated chloride permeability (i.e., increases in amiloride-sensitive
PD correlated with a reduction in low chloride
PD). Given the fact that this low chloride response was
inhibited 44% by DPC, our results are consistent with
CFTR suppression of ENaC channels in the surface airway epithelium. However, differences in the amiloride-sensitive sodium permeability in airways with and without
glands might also be due in part to abundant sodium channels in submucosal gland ducts. In fact, recent investigations have localized high levels of mRNAs for all three of
the ENaC subunits in submucosal gland ducts (35). At face
value, increased ENaC activity and decreased baseline
chloride permeability in xenografts with submucosal glands would be anticipated to activate fluid absorption and decrease ASF volume (i.e., as is seen in CF airways). However, this was not the case. Hence, one would conclude
that although the inverse link between sodium and chloride permeability is interesting, it does not likely account
for differences in ASF volumes.
In conclusion, our results demonstrate that the presence of submucosal glands in the airway significantly alters
the bioelectric properties, the steady-state chloride content, and the volume of airway secretions. One of the most
interesting and novel findings includes the fact that a heat-labile factor secreted by submucosal glands alters the activity of chloride channels (perhaps including CFTR) in
the surface airway epithelium. These findings suggest that
the properties of ion and fluid transport in proximal airways are controlled by a dynamic interaction between submucosal glands and the surface airway epithelium. The relevance of these findings becomes important as the field
continues to deliberate on the importance of ASF composition in the protection of the airway from infection. Several abundant antibacterial compounds in the airway, including lysozyme and
-defensin, have been shown to be
sensitive to the higher salt concentration in ASF from CF
patients (8, 36, 37). Concentrations of chloride in ASF
from both xenografts with and without submucosal glands
are within the range of reported salt concentrations that
begin to inhibit defensin antibacterial properties. However, the antibacterial properties of the airway are likely
controlled by multifactorial influences determining both
the composition and viscoelastic properties of the fluid
that lines the airways. Our data demonstrating that submucosal glands alter the bioelectric properties of the surface airway epithelium suggest that models used to dissect
these pathophysiologic mechanisms should take into account glandular function in the airway.
| |
Footnotes |
|---|
Address correspondence to: John F. Engelhardt, Dept. of Anatomy and Cell Biology, University of Iowa, School of Medicine, 51 Newton Rd., Rm. 1-111 BSB, Iowa City, IA 52242. E-mail: john-engelhardt{at}uiowa.edu
(Received in original form August 30, 1999 and in revised form October 31, 2000).
Acknowledgments: The authors acknowledge the support of grant P30 DK54759 funding the Animal Models and Cell Morphology Cores of the Iowa Center for Gene Therapy of Cystic Fibrosis and Other Genetic Diseases, and grant P30 DK25295 from the DERC Center for supplying cell culture media. They also thank Dr. Terry Ritchie for her editorial assistance in the preparation of this manuscript. This study was supported by grants RO1 DK47967 and P50 HL61234 from the National Institutes of Health/NIDDK.
Abbreviations ASF, airway surface fluid; cAMP, cyclic adenosine monophosphate; CF, cystic fibrosis; CFTR, CF transmembrane conductance regulator; cpt, chlorophenylthio; DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid; DPC, diphenylamine-2-carboxylic acid; EM, electron microscopy; ENaC, epithelial sodium channel; HPBR, Hepes phosphate-buffered Ringer's solution; MEM, minimum essential medium; ORCC, outward rectifying chloride channel; PD, potential difference; SAE, surface airway epithelial; SEM, standard error of the mean; UTP, uridine triphosphate; Vi, input volume; Vl, fluid loss; Vs, ASF volume.
| |
References |
|---|
|
|
|---|
1.
Collins, F. S..
1992.
Cystic fibrosis: molecular biology and therapeutic implications.
Science
256:
774-779
2. Welsh, M. J., L.-C. Tsui, T. F. Boat, and A. L. Beaudet. 1995. Cystic fibrosis. In The Metabolic Basis of Inherited Disease, 7th ed. C. L. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 3799- 3876.
3. Boucher, R. C., M. J. Stutts, M. R. Knowles, L. Cantley, and J. T. Gatzy. 1986. Na+ transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78: 1245-1252 .
4.
Stutts, M. J.,
C. M. Canessa,
J. C. Olsen,
M. Hamrick,
J. A. Cohn,
B. C. Rossier, and
R. C. Boucher.
1995.
CFTR as a cAMP-dependent regulator
of sodium channels.
Science
269:
847-850
5. Matsui, H., B. R. Grubb, R. Tarran, S. H. Randell, J. T. Gatzy, C. W. Davis, and R. C. Boucher. 1998. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95: 1005-1015 [Medline].
6. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236. [Published erratum appears in Cell 87(2):following 355.]
7. Zabner, J., J. J. Smith, P. H. Karp, J. H. Widdicombe, and M. J. Welsh. 1998. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol. Cell. 2: 397-403 . [Medline]
8. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553-560 [Medline].
9. Accurso, F. J.. 1997. Early pulmonary disease in cystic fibrosis. Curr. Opin. Pulmon. Med. 3: 400-403 . [Medline]
10. Jacquot, J., E. Puchelle, J. Hinnrasky, C. Fuchey, C. Bettinger, C. Spilmont, N. Bonnet, A. Dieterle, D. Dreyer, A. Pavirani, et al . 1993. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands [see comments]. Eur. Respir. J. 6: 169-176 [Abstract].
11. Engelhardt, J. F., J. R. Yankaskas, S. A. Ernst, Y. Yang, C. R. Marino, R. C. Boucher, J. A. Cohn, and J. M. Wilson. 1992. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat. Genet. 2: 240-248 [Medline].
12. Ornoy, A., J. Arnon, D. Katznelson, M. Granat, B. Caspi, and J. Chemke. 1987. Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis. Am. J. Med. Genet. 28: 935-947 [Medline].
13. Sturgess, J., and J. Imrie. 1982. Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants. Am. J. Pathol. 106: 303-311 [Abstract].
14. Damjanovich, L., G. T. Szeifert, M. Szabo, and Z. Papp. 1990. Pathological confirmation of foetal cystic fibrosis following prenatal diagnosis. Acta Morphol. Hung. 38: 141-148 [Medline].
15. Basbaum, C. B.. 1986. Regulation of airway secretory cells. Clin. Chest. Med. 7: 231-237 [Medline].
16. Basbaum, C. B., B. Jany, and W. E. Finkbeiner. 1990. The serous cell. Annu. Rev. Physiol. 52: 97-113 [Medline].
17. Guggino, W. B.. 1999. Cystic fibrosis and the salt controversy. Cell 96: 607-610 [Medline].
18. Knowles, M. R., J. M. Robinson, R. E. Wood, C. A. Pue, W. M. Mentz, G. C. Wager, J. T. Gatzy, and R. C. Boucher. 1997. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J. Clin. Invest. 100:2588-2595. [Published erratum appears in J. Clin. Invest. 101(1):285.]
19. Tirouvanziam, R., M. Desternes, A. Saari, E. Puchelle, B. Peault, and T. Chinet. 1998. Bioelectric properties of human cystic fibrosis and non-cystic fibrosis fetal tracheal xenografts in SCID mice. Am. J. Physiol. 274(4, Pt. 1):C875-C882.
20.
Baconnais, S.,
R. Tirouvanziam,
J. M. Zahm,
S. de Bentzmann,
B. Peault,
G. Balossier, and
E. Puchelle.
1999.
Ion composition and rheology of airway liquid from cystic fibrosis fetal tracheal xenografts.
Am. J. Respir. Cell
Mol. Biol.
20:
605-611
21. Zhang, Y., and J. F. Engelhardt. 1999. Airway surface fluid volume and Cl content in cystic fibrosis and normal bronchial xenografts. Am. J. Physiol. 276(2, Pt. 1):C469-C476.
22.
Hull, J.,
W. Skinner,
C. Robertson, and
P. Phelan.
1998.
Elemental content
of airway surface liquid from infants with cystic fibrosis.
Am. J. Respir.
Crit. Care Med.
157:
10-14
23. Quinton, P. M.. 1979. Composition and control of secretions from tracheal bronchial submucosal glands. Nature 279: 551-552 [Medline].
24. Ballard, S. T., J. D. Fountain, S. K. Inglis, M. R. Corboz, and A. E. Taylor. 1995. Chloride secretion across distal airway epithelium: relationship to submucosal gland distribution. Am. J. Physiol. 268(3, Pt. 1):L526-L531.
25.
Boucher, R. C. Jr.,
P. A. Bromberg, and
J. T. Gatzy.
1980.
Airway transepithelial electric potential in vivo: species and regional differences.
J. Appl.
Physiol.
48:
169-176
26.
Boucher, R. C.,
M. J. Stutts, and
J. T. Gatzy.
1981.
Regional differences in bioelectric properties and ion flow in excised canine airways.
J. Appl. Physiol.
51:
706-714
27. Zhang, Y., B. Doranz, J. R. Yankaskas, and J. F. Engelhardt. 1995. Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis. J. Clin. Invest. 96: 2997-3004 .
28. Zhang, Y., J. Yankaskas, J. Wilson, and J. F. Engelhardt. 1996. In vivo analysis of fluid transport in cystic fibrosis airway epithelia of bronchial xenografts. Am. J. Physiol. 270(5, Pt. 1):C1326-C1335.
29.
Engelhardt, J. F.,
E. D. Allen, and
J. M. Wilson.
1991.
Reconstitution of tracheal grafts with a genetically modified epithelium.
Proc. Natl. Acad. Sci.
USA
88:
11192-11196
30. Zhang, Y., Q. Jiang, L. Dudus, J. R. Yankaskas, and J. F. Engelhardt. 1998. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways. Hum. Gene Ther. 9: 635-648 [Medline].
31. Cunningham, S. A., R. T. Worrell, D. J. Benos, and R. A. Frizzell. 1992. cAMP-stimulated ion currents in Xenopus oocytes expressing CFTR cRNA. Am. J. Physiol. 262(3, Pt. 1):C783-C788.
32. Epstein, F. H., and P. Silva. 1985. Na-K-Cl cotransport in chloride-transporting epithelia. Ann. NY Acad. Sci. 456: 187-197 [Abstract].
33.
Picher, M., and
R. C. Boucher.
2000.
Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways.
Am. J. Respir. Cell Mol. Biol.
23:
255-261
34.
Lazarowski, E. R.,
R. C. Boucher, and
T. K. Harden.
2000.
Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide
concentrations [in Process Citation].
J. Biol. Chem.
275:
31061-31068
35. Rochelle, L. G., D. C. Li, H. Ye, E. Lee, C. R. Talbot, and R. C. Boucher. 2000. Distribution of ion transport mRNAs throughout murine nose and lung [in Process Citation]. Am. J. Physiol. 279(Lung Cell. Mol. Physiol.): L14-L24.
36. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M. Wilson. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102: 874-880 [Medline].
37. Morrison, G. M., D. J. Davidson, F. M. Kilanowski, D. W. Borthwick, K. Crook, A. I. Maxwell, J. R. Govan, and J. R. Dorin. 1998. Mouse beta defensin-1 is a functional homolog of human beta defensin-1. Mamm. Genome 9: 453-457 [Medline].
This article has been cited by other articles:
![]() |
X. Liu, M. Luo, L. Zhang, W. Ding, Z. Yan, and J. F. Engelhardt Bioelectric Properties of Chloride Channels in Human, Pig, Ferret, and Mouse Airway Epithelia Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wine Acid in the airways. Focus on "Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis" Am J Physiol Cell Physiol, March 1, 2006; 290(3): C669 - C671. [Full Text] [PDF] |
||||
![]() |
R. Dajani, Y. Zhang, P. J. Taft, S. M. Travis, T. D. Starner, A. Olsen, J. Zabner, M. J. Welsh, and J. F. Engelhardt Lysozyme Secretion by Submucosal Glands Protects the Airway from Bacterial Infection Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 548 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Driskell, X. Liu, M. Luo, M. Filali, W. Zhou, D. Abbott, N. Cheng, C. Moothart, C. D. Sigmund, and J. F. Engelhardt Wnt-responsive element controls Lef-1 promoter expression during submucosal gland morphogenesis Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L752 - L763. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. Rezaei Sabet, Q. Zhou, X. Liu, W. Ding, Y. Zhang, J.-P. Renard, and J. F. Engelhardt Developmental Capacity of Ferret Embryos by Nuclear Transfer Using G0/G1-Phase Fetal Fibroblasts Biol Reprod, June 1, 2003; 68(6): 2297 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Phillips, J. A. Hey, and M. R. Corboz Effects of ion transport inhibitors on MCh-mediated secretion from porcine airway submucosal glands J Appl Physiol, September 1, 2002; 93(3): 873 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, Q. Jiang, M. Rezaei Sabet, Y. Zhang, T. C. Ritchie, and J. F. Engelhardt Conditions for In Vitro Maturation and Artificial Activation of Ferret Oocytes Biol Reprod, May 1, 2002; 66(5): 1380 - 1386. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |